Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

SELVAS Healthcare, Inc. (208370.KQ)

Compare
4,205.00
+55.00
+(1.33%)
At close: April 4 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
31,702,268.07
31,702,268.07
29,812,771.01
27,685,710.22
29,089,193.74
Cost of Revenue
15,140,825.50
15,140,825.50
14,162,523.90
13,567,288.84
15,130,532.62
Gross Profit
16,561,442.57
16,561,442.57
15,650,247.11
14,118,421.38
13,958,661.12
Operating Expense
13,286,614
13,286,614
12,301,067
11,635,883
10,546,288
Operating Income
3,274,828.57
3,274,828.57
3,349,180.11
2,482,538.38
3,412,373.12
Net Non Operating Interest Income Expense
535,758.78
535,758.78
239,342.13
-743,881.32
-543,870.39
Pretax Income
3,298,841.63
3,298,841.63
3,858,022.87
2,851,896.63
2,536,776.56
Tax Provision
146,942.82
146,942.82
-1,311,767.66
39,051.98
65,181.40
Net Income Common Stockholders
3,151,898.80
3,151,898.80
5,169,790.54
2,812,844.65
2,471,595.16
Basic EPS
123.00
--
215.00
121.84
110.24
Diluted EPS
122.00
--
214.00
90.90
110.24
Basic Average Shares
25,625.19
--
24,045.54
23,086.14
22,420.67
Diluted Average Shares
25,835.24
--
24,157.90
30,945.25
22,420.67
Total Operating Income as Reported
3,273,928.84
3,273,928.84
3,345,879.71
2,482,536.56
3,412,372.39
Rent Expense Supplemental
178,394
178,394
189,747
167,384
164,013
Total Expenses
28,427,439.50
28,427,439.50
26,463,590.90
25,203,171.84
25,676,820.62
Net Income from Continuing & Discontinued Operation
3,151,898.80
3,151,898.80
5,169,790.54
2,812,844.65
2,471,595.16
Normalized Income
4,781,793.44
4,781,793.44
5,150,444.74
2,241,131.99
3,285,006.71
Interest Income
771,928
771,928
466,573
129,931
95,624
Interest Expense
236,169
236,169
227,231
511,119
639,496
Net Interest Income
535,758.78
535,758.78
239,342.13
-743,881.32
-543,870.39
EBIT
3,535,010.63
3,535,010.63
4,085,253.87
3,363,015.63
3,176,272.56
EBITDA
4,583,207.63
4,583,207.63
5,095,762.87
4,461,586.63
4,758,510.56
Reconciled Cost of Revenue
15,140,825.50
15,140,825.50
14,162,523.90
13,567,288.84
15,130,532.62
Reconciled Depreciation
1,048,197
1,048,197
1,010,509
1,098,571
1,582,238
Net Income from Continuing Operation Net Minority Interest
3,151,898.80
3,151,898.80
5,169,790.54
2,812,844.65
2,471,595.16
Total Unusual Items Excluding Goodwill
-1,705,881
-1,705,881
25,455
579,650
-834,863
Total Unusual Items
-1,705,881
-1,705,881
25,455
579,650
-834,863
Normalized EBITDA
6,289,088.63
6,289,088.63
5,070,307.87
3,881,936.63
5,593,373.56
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-75,986.36
-75,986.36
6,109.20
7,937.34
-21,451.45
12/31/2021 - 9/1/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade